DeMay Bio

DeMay Bio is developing a biologic drug for Rheumatoid Arthritis that leverages a natural human protein to target a novel, but validated, disease mechanism directly in the joints. The new…

Read More

ELIV5

ELIV5 Therapeutics aims to develop a new class of antifungal drugs that target a critical step in fungal metabolism required for pathogen survival and virulence.   ELIV5 Team: Choukri Ben…

Read More

Agamon

Agamon partners with hospitals, structures their textual clinical data using NLP and provides tools & services for a faster, efficient & scalable way to access clinical data & insights.  …

Read More

Bow Therapeutics

Bow Therapeutics is developing isolation of human monoclonal antibodies against Chikungunya Virus Glycoprotein using Single B-cell sorting Technology.   Bow Therapeutics Team: George Georgiev Jose Quiroz    

Read More

Qlear Chemicals

Qlear Chemicals We develop novel permeabilization and optical clearing reagents for 3D imaging of intact, grossed anatomic pathology samples.   Qlear Chemicals Team: Elif Alpoge  

Read More

Unicrobe

We will provide bacterial genome editing services using CRISPR-Cas technologies for academic and industrial customers interested in improving human health and developing bacterial technologies. Team: Wenyan Jiang – CEO, CSO…

Read More

iLight Biotechnologies

Genetic tools for non-invasive activation and detection of biological processes with deeply penetrating near-infrared light that will make drug discovery process more efficient. iLight Biotechnologies Team: Daria Shcherbakova, PhD. –…

Read More

Microstructure Imaging

We are a service company that improves medical image quality via advanced post-processing and uses this improvement to develop quantitive biomarkers specific to cellular-level pathology. Team: Lieven Nuyttens, CEO Gregory…

Read More

Gentroma

A portable DNA sequencer that can make finding out information about one’s genetic ancestry, disease risk, and other factors available to the masses, cost-effectively. Team: Krista Fretes, CEO Parth Shah,…

Read More